Pharmacological Evaluation of the Anti-inflammatory Activity of Icaritin-a Natural Isoflavone
Year: 2026
Type: article
Abstract: Inflammation is a protective physiological response to harmful stimuli, including infection and tissue injury. However, excessive or persistent inflammation may contribute to the pathogenesis of various diseases. Although several anti-inflammatory agents are available, their prolonged use may be associated with adverse effects. Consequently, natural compounds with potential anti-inflammatory properties have attracted considerable research interest. Icaritin is a naturally occurring prenylated flavonoid derived from Epimedium species and has been reported to exhibit several pharmacological activities, including antioxidant, anticancer, and anti-inflammatory effects. The present study aimed to evaluate the cytotoxic and anti-inflammatory activities of serving as the standard drug. Anti-inflammatory activity was evaluated using the protein denaturation inhibition assay, with aspirin as the reference standard. Icaritin demonstrated an IC50 value of 107.47 µg/mL in the MTT assay. In the protein denaturation assay, icaritin exhibited 69.31 ± 2.45% inhibition at a concentration of 100 µg/mL, compared with 76.21 ± 3.14% inhibition observed with aspirin.These findings indicate that icaritin possesses promising preliminary anti-inflammatory activity. Further studies are warranted to elucidate its mechanism of action and assess its therapeutic potential.
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7234072425
